ArticleJournal of medical biochemistry2025

Efficacy and safety of empagliflozin in patients over 65 with type 2 diabetes mellitus complicating cardiorenal syndromes type II and IV.

Mugen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.